Catalyst Pharma (CPRX)
NASDAQ:CPRX
Holding CPRX?
Track your performance easily

Catalyst Pharma (CPRX) Income Statement

2,103 Followers

Catalyst Pharma Income Statement

Last quarter (Q3 2024), Catalyst Pharma's total revenue was $128.69M, an increase of 25.33% from the same quarter last year. In Q3, Catalyst Pharma's net income was $43.88M. See Catalyst Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 460.48M$ 398.20M$ 214.20M$ 140.83M$ 119.07M$ 102.31M
Cost of Revenue
$ 63.01M$ 51.97M$ 34.39M$ 21.88M$ 17.04M$ 14.76M
Gross Profit
$ 397.47M$ 346.24M$ 179.81M$ 118.95M$ 102.03M$ 87.55M
Operating Expense
$ 218.97M$ 259.43M$ 77.97M$ 66.56M$ 60.73M$ 55.72M
Operating Income
$ 173.97M$ 86.81M$ 101.84M$ 52.38M$ 41.30M$ 31.82M
Net Non Operating Interest Income Expense
------
Other Income Expense
$ 582.00K$ 7.70M$ 2.88M$ -282.00K$ -587.00K$ -1.59M
Pretax Income
$ 188.79M$ 94.51M$ 104.72M$ 52.67M$ 41.89M$ 33.41M
Tax Provision
$ 45.99M$ 23.10M$ 21.64M$ 13.19M$ -33.09M$ 1.53M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 142.80M$ 71.41M$ 83.08M$ 39.48M$ 74.98M$ 31.88M
Basic EPS
$ 1.24$ 0.67$ 0.80$ 0.38$ 0.72$ 0.31
Diluted EPS
$ 1.20$ 0.63$ 0.75$ 0.37$ 0.71$ 0.30
Basic Average Shares
$ 460.65M$ 106.28M$ 103.37M$ 103.38M$ 103.51M$ 102.94M
Diluted Average Shares
$ 494.25M$ 113.75M$ 111.38M$ 107.80M$ 106.24M$ 106.02M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 264.44M$ 311.39M$ 112.36M$ 88.45M$ 77.77M$ 70.48M
Net Income From Continuing And Discontinued Operation
$ 142.80M$ 71.41M$ 83.08M$ 39.48M$ 74.98M$ 31.88M
Normalized Income
$ 140.66M-----
Interest Expense
------
EBIT
$ 193.12M$ 86.81M$ 101.84M$ 52.38M$ 41.30M$ 33.41M
EBITDA
$ 230.58M$ 119.69M$ 103.08M$ 52.58M$ 41.40M$ 33.46M
Currency in USD

Catalyst Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis